Steve is responsible for media relations, internal communications, publications, digital and social content and brand across both the Wellcome Sanger Institute and Wellcome Genome Campus.
My timeline
Connect with me on Twitter
Our follow-up study on WRN is out today @CD_AACR. WRN synthetic-lethality is retained in MSI models of resistance to targeted therapy, chemotherapy, and checkpoint inhibitors (https://cancerdiscovery.aacrjournals.org/content/early/2021/04/08/2159-8290.CD-20-1508). This could expand the cohort of patients benefiting from WRN therapies.
If you're interested in hearing @GosiaTrynka thoughts on this, have a listen to our most recent episode!
@targetvalidate @WGCengage @wellcometrust @sangerinstitute
https://open.spotify.com/episode/7DDmigqBfozoVNZvupSPsN?si=M2D0ZDztS1264IzZJa3Bzw https://twitter.com/WomenWhoCode/status/1380237799186661379
What is your advice for dealing with #impostersyndrome?
In other words, the placenta can "live fast and die young," said @sangerinstitute's Sam Behjati.
Unlike the fetus, which would have to live with the consequences for decades, the placenta can tolerate being the "Wild West of the human genome."
https://www.quantamagazine.org/new-genomic-study-of-placenta-finds-deep-links-to-cancer-20210408/